肌萎缩侧索硬化症死亡证明诊断的准确性。
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.
作者信息
Chiò A, Magnani C, Oddenino E, Tolardo G, Schiffer D
机构信息
II Department of Neurology, University of Turin, Ospedale Molinette, Torino, Italy.
出版信息
J Epidemiol Community Health. 1992 Oct;46(5):517-8. doi: 10.1136/jech.46.5.517.
Abstract
STUDY OBJECTIVE
The aim was to determine the reliability of official mortality statistics in estimating long term trends of amyotrophic lateral sclerosis (ALS) in Italy.
DESIGN
The study was a mortality follow up of cases of ALS.
SETTING
Piedmond Region, northern Italy.
SUBJECTS
Cases of ALS were identified from multiple sources between 1966 and 1985.
MAIN RESULTS
Cause of death was determined for the cases who died between 1970 and 1985. Death certificates were obtained in 488 out of 510 cases (95.7%). ALS was mentioned in 365 (74.8%) of cases. The most frequent erroneous diagnoses were multiple sclerosis and malignant tumours. Demographic variables, such as sex, age at death, province of death, and calendar year of death, did not influence the percentage of true positive cases significantly.
CONCLUSIONS
The death certificate diagnosis of ALS appears to be adequate for use in descriptive and analytical epidemiology.
摘要
研究目的
本研究旨在确定官方死亡率统计数据在评估意大利肌萎缩侧索硬化症（ALS）长期趋势方面的可靠性。
设计
本研究为ALS病例的死亡率随访研究。
地点
意大利北部皮埃蒙特大区。
研究对象
1966年至1985年间通过多种来源确定的ALS病例。
主要结果
确定了1970年至1985年间死亡病例的死因。510例病例中有488例（95.7%）获得了死亡证明。其中365例（74.8%）病例的死亡证明中提及了ALS。最常见的错误诊断为多发性硬化症和恶性肿瘤。人口统计学变量，如性别、死亡年龄、死亡省份和死亡年份，对真阳性病例的百分比没有显著影响。
结论
ALS的死亡证明诊断似乎足以用于描述性和分析性流行病学研究。
相似文献
1
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.肌萎缩侧索硬化症死亡证明诊断的准确性。
J Epidemiol Community Health. 1992 Oct;46(5):517-8. doi: 10.1136/jech.46.5.517.
2
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.意大利南北地区肌萎缩侧索硬化症死亡证明的准确性差异显著：对死亡率研究的影响。
Neuroepidemiology. 2004 Jan-Apr;23(1-2):73-7. doi: 10.1159/000073978.
3
Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study.法国利穆赞地区死亡证明在肌萎缩侧索硬化症（ALS）病例识别中的有效性。一项基于人群的研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2020 May;21(3-4):228-234. doi: 10.1080/21678421.2020.1746811. Epub 2020 Apr 10.
4
The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy.意大利雷焦艾米利亚肌萎缩侧索硬化症的流行病学
Amyotroph Lateral Scler. 2008 Dec;9(6):350-3. doi: 10.1080/17482960802196150.
5
[Causes of death in amyotrophic lateral sclerosis : Results from the Rhineland-Palatinate ALS registry].[肌萎缩侧索硬化症的死因：莱茵兰-普法尔茨州肌萎缩侧索硬化症登记处的结果]
Nervenarzt. 2017 Aug;88(8):911-918. doi: 10.1007/s00115-017-0293-3.
6
Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Project.国际疾病分类第十版（ICD - 10）死亡证明编码用于识别肌萎缩侧索硬化症（ALS）患者的准确性和实用性：南卡罗来纳州ALS监测试点项目的结果
Amyotroph Lateral Scler. 2012 Jan;13(1):69-73. doi: 10.3109/17482968.2011.614253. Epub 2011 Sep 19.
7
Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers.通过全国强制性健康登记系统评估2009年至2015年挪威肌萎缩侧索硬化症的患病率。
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):303-310. doi: 10.1080/21678421.2017.1418004. Epub 2017 Dec 22.
8
Validating population-based registers for ALS: how accurate is death certification?基于人群的 ALS 登记验证：死亡证明的准确性如何？
J Neurol. 2010 Aug;257(8):1235-9. doi: 10.1007/s00415-010-5494-7. Epub 2010 Feb 12.
9
Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.在丹麦人群中利用死亡证明和医院出院数据对肌萎缩侧索硬化症诊断情况的比较。
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):224-9. doi: 10.3109/21678421.2014.988161. Epub 2015 May 6.
10
Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-up.初诊为肌萎缩侧索硬化症（ALS）的患者真的是ALS吗？一项基于人群的长期随访研究结果
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):221-226. doi: 10.1080/21678421.2016.1249886. Epub 2016 Nov 28.
引用本文的文献
1
A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.职业运动员和大学生运动员患神经退行性疾病和神经认知障碍的风险的系统评价。
Neurol Sci. 2022 Dec;43(12):6667-6691. doi: 10.1007/s10072-022-06319-x. Epub 2022 Aug 17.
2
Systematic literature review of the epidemiology of glyphosate and neurological outcomes.系统性文献回顾草甘膦与神经学结局的流行病学研究。
Int Arch Occup Environ Health. 2023 Jan;96(1):1-26. doi: 10.1007/s00420-022-01878-0. Epub 2022 May 23.
3
Contact Sports as a Risk Factor for Amyotrophic Lateral Sclerosis: A Systematic Review.接触性运动作为肌萎缩侧索硬化症的一个风险因素：一项系统综述
Global Spine J. 2019 Feb;9(1):104-118. doi: 10.1177/2192568218813916. Epub 2019 Jan 31.
4
Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies.咖啡、茶和咖啡因摄入与八项前瞻性队列研究中肌萎缩侧索硬化症死亡率的关系的汇总分析。
Eur J Neurol. 2019 Mar;26(3):468-475. doi: 10.1111/ene.13840. Epub 2018 Nov 9.
5
Increase in assisted suicide in Switzerland: did the socioeconomic predictors change? Results from the Swiss National Cohort.瑞士协助自杀案例增加：社会经济预测因素有变化吗？来自瑞士国民队列的结果。
BMJ Open. 2018 Apr 17;8(4):e020992. doi: 10.1136/bmjopen-2017-020992.
6
Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: A systematic review.用于识别运动神经元病病例的常规收集医疗保健数据的准确性：一项系统综述。
PLoS One. 2017 Feb 28;12(2):e0172639. doi: 10.1371/journal.pone.0172639. eCollection 2017.
7
Population-based risks for cancer in patients with ALS.肌萎缩侧索硬化症患者基于人群的癌症风险
Neurology. 2016 Jul 19;87(3):289-94. doi: 10.1212/WNL.0000000000002757. Epub 2016 May 11.
8
Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort.基于人群队列研究中的兵役与肌萎缩侧索硬化症
Epidemiology. 2015 Nov;26(6):831-8. doi: 10.1097/EDE.0000000000000376.
9
Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.确诊肌萎缩侧索硬化症病例队列中的生存情况及死因
PLoS One. 2015 Jul 14;10(7):e0131965. doi: 10.1371/journal.pone.0131965. eCollection 2015.
10
Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.在丹麦人群中利用死亡证明和医院出院数据对肌萎缩侧索硬化症诊断情况的比较。
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):224-9. doi: 10.3109/21678421.2014.988161. Epub 2015 May 6.
本文引用的文献
1
Motor neuron disease in England and Wales, 1959-1979.1959 - 1979年英格兰和威尔士的运动神经元病
J Neurol Neurosurg Psychiatry. 1983 Mar;46(3):197-205. doi: 10.1136/jnnp.46.3.197.
2
Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population.1966 - 1980年意大利都灵省的运动神经元病。非选择性人群的生存分析。
J Neurol Sci. 1984 Nov-Dec;66(2-3):165-73. doi: 10.1016/0022-510x(84)90004-2.
3
The reliability of death certificate reporting for amyotrophic lateral sclerosis.肌萎缩侧索硬化症死亡证明报告的可靠性。
J Chronic Dis. 1971 Jun;24(1):5-8. doi: 10.1016/0021-9681(71)90053-1.
4
Multiple sclerosis and motor neurone disease: survival and how certified after death.多发性硬化症与运动神经元病：生存率及死后认证方式
J Epidemiol Community Health. 1987 Mar;41(1):14-7. doi: 10.1136/jech.41.1.14.
5
Increasing trend of ALS in France and elsewhere: are the changes real?法国及其他地区肌萎缩侧索硬化症病例数呈上升趋势：这些变化是真实的吗？
Neurology. 1989 Jun;39(6):768-73. doi: 10.1212/wnl.39.6.768.
6
Rising mortality from motoneuron disease in the USA, 1962-84.1962年至1984年美国运动神经元病死亡率上升。
Lancet. 1989 Apr 1;1(8640):710-3. doi: 10.1016/s0140-6736(89)92218-6.
7
The mortality of motor neuron disease in Sweden.瑞典运动神经元疾病的死亡率。
Arch Neurol. 1990 Jan;47(1):42-6. doi: 10.1001/archneur.1990.00530010050018.
8
Amyotrophic lateral sclerosis in Finland. I: An epidemiologic study.芬兰的肌萎缩侧索硬化症。I：一项流行病学研究。
Acta Neurol Scand. 1977 Sep;56(3):185-93. doi: 10.1111/j.1600-0404.1977.tb01424.x.
9
Changing mortality patterns of motor neuron disease in Japan.日本运动神经元病死亡率模式的变化
J Neurol Sci. 1977 Jul;32(3):411-24. doi: 10.1016/0022-510x(77)90023-5.
Zotero 插件